Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
13.00
-0.40 (-2.99%)
Jan 23, 2025, 12:28 PM EST - Market open
Arcus Biosciences Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Arcus Biosciences stock have an average target of 34.5, with a low estimate of 20 and a high estimate of 50. The average target predicts an increase of 165.38% from the current stock price of 13.00.
Analyst Consensus: Buy
* Price targets were last updated on Nov 6, 2024.
Analyst Ratings
The average analyst rating for RCUS stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
---|---|---|---|---|---|---|
Strong Buy | 5 | 5 | 4 | 4 | 4 | 4 |
Buy | 5 | 5 | 6 | 6 | 6 | 6 |
Hold | 1 | 1 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 11 | 11 | 12 | 12 | 12 | 12 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $20 | Hold | Reiterates | $20 | +53.85% | Nov 6, 2024 |
Barclays | Barclays | Buy Maintains $25 → $29 | Buy | Maintains | $25 → $29 | +123.08% | Oct 25, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $20 | Hold | Reiterates | $20 | +53.85% | Oct 24, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Initiates $20 | Hold | Initiates | $20 | +53.85% | Oct 21, 2024 |
Wells Fargo | Wells Fargo | Buy Initiates $29 | Buy | Initiates | $29 | +123.08% | Oct 8, 2024 |
Financial Forecast
Revenue This Year
266.35M
from 117.00M
Increased by 127.65%
Revenue Next Year
215.68M
from 266.35M
Decreased by -19.02%
EPS This Year
-3.47
from -4.15
EPS Next Year
-4.92
from -3.47
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 285.6M | 606.2M | 540.8M | |||
Avg | 266.4M | 215.7M | 232.2M | |||
Low | 239.1M | 29.4M | 88.2M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 144.1% | 127.6% | 150.7% | |||
Avg | 127.6% | -19.0% | 7.7% | |||
Low | 104.4% | -89.0% | -59.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -2.57 | -3.56 | -1.93 | |||
Avg | -3.47 | -4.92 | -4.50 | |||
Low | -4.06 | -6.60 | -6.08 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.